戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  is inhibited by FGF-1, heparan sulfate, and heparinoids.
2                                          The heparinoids also showed similar differences in their abi
3 d biological evaluation of a novel series of heparinoid amphiphiles as inhibitors of heparanase and S
4   Surprisingly, heparin, chemically modified heparinoids, and monoclonal antibodies to heparan sulfat
5 ledge, this is the first biologically active heparinoid anticoagulant which contains a different suga
6 anticoagulation regimens, including heparin, heparinoids, antithrombins, or fibrinolytics (e.g., tiss
7            Low-molecular-weight heparins and heparinoids are superior to unfractionated heparin in th
8                       This finding suggested heparinoids as possible inhibitors.
9                           As a result, these heparinoids can control the alternative complement pathw
10 lly we showed that certain low anticoagulant heparinoids can inhibit properdin binding to tubular HS,
11                               This synthetic heparinoid could facilitate the development of agents to
12 bitor (e.g., argatroban or lepirudin) or the heparinoid danaparoid (where available) reduces the risk
13  Stroke Treatment, a randomized trial of the heparinoid danaparoid, were analyzed to determine whethe
14 contrast, smaller oligomers or the synthetic heparinoid fondaparinux were not able to block the bindi
15 ed with unfractionated heparin, the modified heparinoids had inhibitory activity in this general orde
16           Indeed, heparin-like molecules, or heparinoids, have previously been proposed as a treatmen
17 nteraction and clearly differ from properdin-heparinoid interaction.
18   Interaction of anti-thrombin III (AT) with heparinoids is studied using a mixture of oligoheparin m
19                                     In turn, heparinoid-like gemini disaccharides (4a and 4b) were pr
20                 Experimental work shows that heparinoids may have neuroprotective properties.
21 vides access to structural variants of small heparinoid oligomers as versatile building blocks for ge
22 s the synthetically most challenging unit of heparinoid oligosaccharides; therefore, there is a high
23 t compared heparins (unfractionated heparin, heparinoids, or low-molecular-weight heparin) with aspir
24 d atrial fibrillation treated with heparins, heparinoids, or vitamin K antagonists (VKAs) to prevent
25 e of idraparinux, an excellent anticoagulant heparinoid pentasaccharide, we demonstrated that l-iduro
26                                              Heparinoids prevented venom cytotoxicity through binding
27 the US Food and Drug Administration-approved heparinoid tinzaparin was found to reduce tissue damage
28 n be manipulated with some low anticoagulant heparinoids, which can be important for preventing compl
29 w the creation of a variety of heparosan and heparinoids with utility for medical applications.